Back to 
CIBC Private Wealth Group LLC
CIBC Private Wealth Group LLC
BCLI
Showing 0 of 7 quarters
Position history for CIBC Private Wealth Group LLC's holdings in BRAINSTORM CELL THERAPEUTICS
No. CIBC Private Wealth Group exited its BCLI (Brainstorm Cell Therapeutics) position in Q2 2020. Its Q1 2020 13F listed 17,484 shares worth $81,000. CIBC Private Wealth Group already held BCLI in its Q4 2018 13F, the earliest on record, and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.